Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
Quidel: No Correlation Between COVID-19 Cases And Stock Price
10:00am, Tuesday, 17'th Aug 2021
Our regression analysis of the percentage change in COVID-19 daily cases to the percentage change in Quidel's stock price shows no significant relationship between COVID-19 cases and Quidel's stock pr
Why Quidel Stock Was Falling on Friday
03:09pm, Friday, 06'th Aug 2021
The company's Q2 headline numbers were nowhere near analyst estimates.
Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales
08:03am, Friday, 06'th Aug 2021
Quidel Corporation (NASDAQ: QDEL) reported after the close of the market Thursday that its second-quarter revenues fell 12% Y/Y to $176.6 million, below the consensus of $194.5 million. The decline
Quidel Corporation (QDEL) CEO Douglas Bryant on Q2 2021 Results - Earnings Call Transcript
10:10pm, Thursday, 05'th Aug 2021
Quidel Corporation (QDEL) CEO Douglas Bryant on Q2 2021 Results - Earnings Call Transcript
3 Reasons I Gave Up on Quidel
07:49am, Wednesday, 28'th Jul 2021
The company's next earnings report could be another disappointment.
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today a
Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on the Move Today
12:16pm, Tuesday, 20'th Jul 2021
Stocks for companies developing or already distributing a vaccine for covid are on the move Tuesday and we've got all the details. The post Covid Vaccine Stocks: Why NVAX, OCGN, MRNA and QDEL Are on t
Why Quidel Soared by Almost 8% on Monday
04:29pm, Monday, 19'th Jul 2021
The company announces a potentially major testing deal in Delaware.
State of Delaware Selects Quidel for COVID-19 Testing Program at Schools
10:30am, Monday, 19'th Jul 2021
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,
Quidel Receives CE Mark for Savanna® Multiplex Molecular Analyzer and Respiratory Viral Panel
09:15am, Monday, 12'th Jul 2021
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems,
Quidel Recalls Lyra COVID Diagnostic Test Due To Potential False Negative Results
06:21am, Thursday, 08'th Jul 2021
Quidel Corporation (NASDAQ: QDEL) is recalling its Lyra COVID-19 Assay test due to a high risk of false-negative results in patients with high amounts of the virus. The FDA gave the molecular COVID
Why Quidel Shot 4% Higher Today
06:29pm, Tuesday, 29'th Jun 2021
There might be a surge in demand for coronavirus testing kits in the very near future.
Quidel: Primed For Acquisitions
01:25am, Monday, 28'th Jun 2021
Quidel: Primed For Acquisitions
With Lyme Disease on the Rise Nationwide, Quidel Corporation Urges Early Testing With Its Rapid Point-of-Care Test
01:04pm, Thursday, 24'th Jun 2021
SAN DIEGO--(BUSINESS WIRE)-- #LymeDisease--Lyme disease is on the rise nationwide and has the potential to affect as many as 476,000 citizens before the year is out.
These Stocks Are Better Priced Compared To Abbott
10:50am, Monday, 21'st Jun 2021
We believe that there are other stocks in the healthcare sector that are currently better valued than Aboott Laboratories. Abbott's current price-to-operating income ratio (P/EBIT) of 30x is much high
